Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TOP2A | P11388 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.43 |
| ▸ | FABP7 | O15540 | 1/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9906753 | 0.95 | KMT2A (0.58) | KMT2AEPHX2CYP1A2TOP2APOLB | |
| Beta-Alanine SCHEMBL1883914 | 0.92 | KMT2A (0.64) | KMT2AEPHX2CYP1A2TOP2ACASP3 | |
| SCHEMBL20758998 | 0.90 | KMT2A (0.74) | KMT2AEPHX2TOP2A | |
| SCHEMBL6187733 | 0.90 | KMT2A (0.65) | KMT2AEPHX2CASP3FABP7FABP5 | |
| SCHEMBL12620066 | 0.87 | KMT2A (0.65) | KMT2AEPHX2CASP3FABP7FABP5 | |
| SCHEMBL14490950 | 0.87 | KMT2A (0.55) | KMT2AEPHX2CYP1A2POLBCASP3 | |
| SCHEMBL20665020 | 0.86 | KMT2A (0.56) | KMT2AEPHX2CYP1A2POLBCASP3 | |
| SCHEMBL12665707 | 0.85 | KMT2A (0.67) | KMT2AEPHX2CASP3FABP7FABP5 | |
| SCHEMBL31419531 | 0.85 | KMT2A (0.66) | KMT2AEPHX2CASP3CXCR2FABP7 | |
| SCHEMBL92796 | 0.85 | KMT2A (0.66) | KMT2AEPHX2CASP3CXCR2FABP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9139615-B2 | High-affinity, dimeric inhibitors of PSD-95 as efficient neuroprotectants against ischemic brain damage and for treatment of pain | UNIVERSITY OF COPENHAGEN (DK) | 2015-09-22 | — | — | US | disclosed |